NSPR

Latest SEC Filings & News for NSPR

1 most recent filing and news item mentioning NSPR. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/NSPR/news?limit=20"

Pull NSPR filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

InspireMD reports 100% device success in CGuard Prime TCAR trial

InspireMD announced positive 30-day results from CGUARDIANS II trial showing 100% acute device success with zero major adverse events for its CGuard Prime 80cm stent in TCAR procedures. The company expects FDA approval in H2 2026, potentially expanding its addressable market to i

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.